Abvc Biopharma Stock Price on October 18, 2024
| ABVC Stock | USD 0.51 0.01 1.92% |
Below is the normalized historical share price chart for ABVC Biopharma extending back to November 10, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ABVC Biopharma stands at 0.51, as last reported on the 26th of November, with the highest price reaching 0.54 and the lowest price hitting 0.50 during the day.
If you're considering investing in ABVC Stock, it is important to understand the factors that can impact its price. ABVC Biopharma secures Sharpe Ratio (or Efficiency) of -0.0482, which signifies that the company had a -0.0482% return per unit of volatility over the last 3 months. ABVC Biopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABVC Biopharma's Mean Deviation of 3.73, market risk adjusted performance of 0.5178, and Variance of 33.16 to double-check the risk estimate we provide.
At present, ABVC Biopharma's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 15.2 M, whereas Common Stock is forecasted to decline to 7,543. . As of November 26, 2024, Price To Sales Ratio is expected to decline to 31.34. In addition to that, Price Earnings Ratio is expected to decline to -0.5. ABVC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2017 | 200 Day MA 0.8737 | 50 Day MA 0.6005 | Beta 0.816 |
ABVC |
Sharpe Ratio = -0.0482
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABVC |
Estimated Market Risk
| 5.84 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ABVC Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABVC Biopharma by adding ABVC Biopharma to a well-diversified portfolio.
Price Book 0.8039 | Enterprise Value Ebitda (1.90) | Price Sales 49.2665 | Shares Float 9.1 M | Wall Street Target Price 2.02 |
ABVC Biopharma Valuation on October 18, 2024
It is possible to determine the worth of ABVC Biopharma on a given historical date. On October 18, 2024 ABVC was worth 0.55 at the beginning of the trading date compared to the closed value of 0.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ABVC Biopharma stock. Still, in general, we apply an absolute valuation method to find ABVC Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ABVC Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ABVC Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.53 | 0.56 | 0.52 | 0.55 | 54,688 | |
10/18/2024 | 0.55 | 0.55 | 0.53 | 0.55 | 62,247 |
| 0.55 | 0.56 | 0.53 | 0.54 | 35,100 |
| Backtest ABVC Biopharma | | | ABVC Biopharma History | | | ABVC Biopharma Valuation | Previous | Next |
ABVC Biopharma Trading Date Momentum on October 18, 2024
| On October 21 2024 ABVC Biopharma was traded for 0.54 at the closing time. The top price for the day was 0.56 and the lowest listed price was 0.53 . The trading volume for the day was 35.1 K. The trading history from October 21, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.82% . The overall trading delta against the current closing price is 25.45% . |
ABVC Biopharma Fundamentals Correlations and Trends
By evaluating ABVC Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ABVC Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ABVC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ABVC Biopharma Stock history
ABVC Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ABVC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ABVC Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ABVC Biopharma stock prices may prove useful in developing a viable investing in ABVC Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.3 M | 4.6 M | |
| Net Loss | -14.8 M | -14 M |
ABVC Biopharma Stock Technical Analysis
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ABVC Biopharma Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
ABVC Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ABVC Biopharma November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how ABVC Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ABVC Biopharma shares will generate the highest return on investment. By undertsting and applying ABVC Biopharma stock market strength indicators, traders can identify ABVC Biopharma entry and exit signals to maximize returns
ABVC Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ABVC Biopharma's price direction in advance. Along with the technical and fundamental analysis of ABVC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ABVC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (1.24) | |||
| Treynor Ratio | 0.5078 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |